Skip to main content

Table 2 Multivariate Cox regression analysis of triglyceride levels with mortality in different models

From: A dose-independent association of triglyceride levels with all-cause mortality among adults population

 

Model I

HR (95%CI), P-value

Model II

HR (95%CI), P-value

Model III

HR (95%CI), P-value

All-cause mortality

 Triglycerides (per mmol/L increment)

1.17 (1.13, 1.21) <  0.0001

1.07 (1.02, 1.12) 0.0021

1.08 (1.02, 1.15) 0.0085

Triglycerides groups, mg/dL

  <  150

1.0

1.0

1.0

 150–200

1.31 (1.16, 1.48) < 0.0001

1.00 (0.89, 1.13) 0.9414

0.97 (0.84, 1.12) 0.7249

 200–249

1.39 (1.19, 1.62) < 0.0001

1.03 (0.88, 1.20) 0.7255

1.06 (0.89, 1.27) 0.5172

  ≥ 250

1.48 (1.28, 1.70) < 0.0001

1.32 (1.14, 1.51) 0.0001

1.34 (1.12, 1.60) 0.0016

P for trend

<  0.001

0.002

0.007

Cardiovascular mortality

 Triglycerides (per mmol/L increment)

1.22 (1.13, 1.31) < 0.0001

1.16 (1.06, 1.27) 0.0009

1.10 (0.97, 1.24) 0.1482

Triglycerides groups, mg/dL

  < 150

1.0

1.0

1.0

 150–200

1.67 (1.30, 2.14) < 0.0001

1.28 (1.00, 1.65) 0.0504

1.01 (0.75, 1.37) 0.9349

 200–249

1.77 (1.29, 2.41) 0.0004

1.31 (0.96, 1.79) 0.0909

1.19 (0.82, 1.71) 0.3544

  ≥ 250

1.61 (1.18, 2.18) 0.0025

1.53 (1.12, 2.08) 0.0068

1.26 (0.85, 1.88) 0.2517

P for trend

< 0.001

0.002

0.203

  1. Notes: Multivariate Cox regression was performed to examine the association between triglyceride levels and mortality
  2. Data are shown in HRs and 95%CI
  3. HR hazard ratios; CI confidence intervals
  4. Model I adjust for none
  5. Model II adjust for age, gender and BMI
  6. Model III adjust for age, gender, race, education level, smoking, body mass index, systolic blood pressure, estimated glomerular filtration rate, energy, C-reactive protein, total cholesterol, high density lipoprotein cholesterol, hypertension, diabetes, and medicine using (antihypertensive drugs, hypoglycemic agents, lipid-lowering drugs, and antiplatelet drugs)